| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/07/2007 | CN1302815C Toluidine blue O drug substance and use thereof for in VIVO Staining and chemo therapeutic treatment of dysplastic tissues |
| 03/07/2007 | CN1302814C Use of contrast agents in manufacture of diagnostic agent for visualisation of intestinal lumen |
| 03/06/2007 | US7186879 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 03/06/2007 | US7186556 Modulating transcription of genes in vascular cells |
| 03/06/2007 | US7186400 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 03/06/2007 | US7186399 Complexing; binding epitopes to surfaces; imaging; detection thrombosis, infections, cancer; acoustic reflection |
| 03/06/2007 | US7186398 Fe/Au nanoparticles and methods |
| 03/06/2007 | US7186397 Cancer diagnosis; antitumor agents |
| 03/01/2007 | WO2007024715A2 Dual variable domain immunoglobin and uses thereof |
| 03/01/2007 | WO2007024705A2 Method of treating depression using a tnf-alpha antibody |
| 03/01/2007 | WO2007024429A2 Cellular or organelle-entrapped nanoparticles |
| 03/01/2007 | WO2006073711A3 Use of a matrix comprising a contrast agent in soft tissues |
| 03/01/2007 | WO2006064451A3 Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy |
| 03/01/2007 | US20070048365 Edible coded microsubstrate for pharmaceuticals |
| 03/01/2007 | US20070048361 Patches and uses thereof |
| 03/01/2007 | US20070048228 Heat pressing a mixture of an active ingredient with abuse potential, a high strength polymer, and a wax into a controlled release dosage form |
| 03/01/2007 | US20070048226 Biochemical marker detection device |
| 03/01/2007 | US20070048225 NK3 receptor in vivo assay |
| 03/01/2007 | US20070048224 Method and apparatus to sense hydration level of a person |
| 03/01/2007 | DE102005039136A1 Verbesserung der Röntgensichtbarkeit und Korrosionsbeständigkeit von NiTi Stents unter Einsatz von Nieten aus Sandwichmaterial Improve the radiopacity and corrosion resistance of NiTi stents using rivets made of sandwich material |
| 03/01/2007 | CA2618482A1 Dual variable domain immunoglobin and uses thereof |
| 03/01/2007 | CA2615560A1 Compositions and methods to control angiogenesis with cupredoxins |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757269A2 Pulmonary formulation comprising silicon particles |
| 02/28/2007 | EP1757186A1 Restless legs syndrome/periodic appendicular dyskinesia model animal |
| 02/28/2007 | EP1756270A2 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 02/28/2007 | EP1755685A2 Methods for autologous stem cell transplantation |
| 02/28/2007 | EP1755659A2 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation |
| 02/28/2007 | EP1755638A1 Multiple agent therapy for sexual dysfunction |
| 02/28/2007 | EP1755584A1 Treatment of myopia |
| 02/28/2007 | EP1531872B1 Method and apparatus for producing contrast agents for magnetic resonance imaging |
| 02/28/2007 | EP1487762B1 Radiofluorination methods |
| 02/28/2007 | EP1392666B1 Biologically active methylene blue derivatives |
| 02/28/2007 | EP1067968B1 Methods for evaluating a compound for its effect on skin |
| 02/28/2007 | EP1045838B1 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid |
| 02/28/2007 | CN1921897A Wound dressings comprising a protein polymer and a polyfunctional spacer |
| 02/28/2007 | CN1919345A Obstruction nephrosis animal model and preparing method thereof |
| 02/28/2007 | CN1301750C Conjugates of macrocyclic metal complexes with biomolucules and utilization thereof for producing agents for use in NMR diagnosis and radiodiagnosis and radiotherapy |
| 02/27/2007 | US7183389 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 02/27/2007 | US7183313 Keto cannabinoids with therapeutic indications |
| 02/27/2007 | US7182934 Contrast agents |
| 02/27/2007 | US7182933 Biomolecule carrier bearing molecules that bind to a cellular adhesion molecule expressed on endothelial cell |
| 02/27/2007 | CA2352571C In vivo biosensor apparatus and method of use |
| 02/22/2007 | WO2007021621A2 In vivo imaging and therapy with magnetic nanoparticle conjugates |
| 02/22/2007 | WO2007020450A2 Imaging agent comprising iron containing colloidal particle conjugated to oligosaccharides |
| 02/22/2007 | WO2006118916A3 Methods and compositions for polytopic vaccination |
| 02/22/2007 | WO2006073586A8 Radiation dosimetry and blocking antibodies and methods and uses threfor in the treatment of cancer |
| 02/22/2007 | WO2005089518A3 Uch-l1 expression and cancer therapy |
| 02/22/2007 | US20070044165 Non-human mammal model comprising heterologous nucleated cells - use for screening compounds |
| 02/22/2007 | US20070043289 Method and Apparatus Including Use of Metalloporphyrins for Subsequent Optimization of Radiosurgery and Radiotherapy |
| 02/22/2007 | US20070042507 Composite nanoparticles |
| 02/22/2007 | US20070042414 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 02/22/2007 | US20070041909 Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
| 02/22/2007 | US20070041908 Injectable composite for the magnetocytolysis of bone metastatic cells |
| 02/22/2007 | US20070041907 Immunoglobulin molecules with improved characteristics |
| 02/22/2007 | US20070041906 Bone substitute composition |
| 02/22/2007 | US20070041905 Method of treating depression using a TNF-alpha antibody |
| 02/22/2007 | US20070041904 Peptides whose uptake by cells is controllable |
| 02/22/2007 | CA2619577A1 Gene disruptions, compositions and methods relating thereto |
| 02/21/2007 | EP1753509A2 Biomolecular contrast agents for therapy optimization in radiation therapy with proton or ion beams |
| 02/21/2007 | EP1753468A2 Carboranylporphyrins and uses thereof |
| 02/21/2007 | EP1753466A2 Copolymers comprising positively and negatively charged aminoacids conjugated to chelants |
| 02/21/2007 | EP1753465A1 Assay for transmissible spongiform encephalopathies |
| 02/21/2007 | EP0797456B1 Anticancer drug with a cytostatic and a contrasting agent |
| 02/21/2007 | CN1915971A Prostaglandin-like compound and its uses for treatment of external secretion disorders |
| 02/21/2007 | CN1301134C Novel immune effect compound |
| 02/20/2007 | US7181266 Materials and methods for near-infrared and infrared lymph node mapping |
| 02/20/2007 | US7179449 Enhanced ultrasound detection with temperature-dependent contrast agents |
| 02/20/2007 | US7179448 Recombinant constructs of Borrelia burgdorferi |
| 02/20/2007 | US7179447 Type I interferon-producing cells and uses thereof |
| 02/20/2007 | US7179446 Administering to mammal vitronectin receptor targeted imaging agent and a perfusion imaging agent; concurrently detecting vitronectin receptor targeted imaging agent bound at vitronectin receptor and perfusion imaging agent; imaging |
| 02/20/2007 | US7179227 Skin condition observation apparatus |
| 02/15/2007 | WO2007019055A2 Cell delivery fluid for prevention of cellsettling in delivery system |
| 02/15/2007 | WO2007018273A1 Composition for delivering diagnostic agent containing sugar-modified liposome |
| 02/15/2007 | WO2007018272A1 Sugar-modified liposome and composition for drug delivery containing the liposome |
| 02/15/2007 | WO2007016790A1 Intra-operative head & neck nerve mapping |
| 02/15/2007 | WO2007016762A1 Perylenequinone derivatives and uses thereof |
| 02/15/2007 | WO2007002109A3 Multidentate pyrone-derived chelators for medicinal imaging and chelation |
| 02/15/2007 | WO2006092584A3 Radioisotope labelled biological compositions, and their use in accelerator mass spectrometry |
| 02/15/2007 | WO2006085908A3 Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant |
| 02/15/2007 | WO2006036071A3 Urokinase plasminogen activator receptor targeted contrast agent |
| 02/15/2007 | WO2005113059A3 Disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 02/15/2007 | WO2005105154A8 Polymer conjugate releasable under mild thiolytic conditions |
| 02/15/2007 | US20070039064 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| 02/15/2007 | US20070039063 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy |
| 02/15/2007 | US20070038077 Stationary target imaging |
| 02/15/2007 | US20070036729 Compositions containing magnetic iron oxide particles, and use of said compositions in imaging methods |
| 02/15/2007 | US20070036728 Mixing hyaluronic acid and a hydrazide with a cross-linking agent in an aqueous solution, adding a nonpolar organic solvent and a surfactant to form an oil-in-water emulsion; and lowering the pH of the reaction to allow intramolecular and intermolecular cross-linking; Fe2O3 |
| 02/15/2007 | US20070036727 Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "cest" applications |
| 02/15/2007 | US20070036726 Diagnosing the health of the eye by staining the tear film with a staining dye, everting the upper eyelid, and observing the lid wiper portion of the everted eyelid for infiltration of the staining dye into the cells thereof; dry eye diagnosis |
| 02/15/2007 | US20070036725 Imaging of protease activity in live cells using activity based probes |
| 02/15/2007 | US20070036724 Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates |
| 02/15/2007 | US20070036723 Kinematic adhesive fluorescence measurement patch |
| 02/15/2007 | US20070036722 Separation processes |
| 02/15/2007 | US20070036721 Methods and compositions for in vivo inflammation monitoring |
| 02/15/2007 | CA2820233A1 Perylenequinone derivatives and uses thereof |
| 02/15/2007 | CA2618443A1 Intra-operative head & neck nerve mapping |
| 02/15/2007 | CA2615510A1 Perylenequinone derivatives and uses thereof |
| 02/14/2007 | EP1752152A1 Agent for visualizing transparent tissue |
| 02/14/2007 | EP1750733A1 METHOD OF ADMINISTERING PORCINE B-DOMAINLESS fVIII |